Nevada Health and Bioscience Asset Corporation

Nevada Health and Bioscience Asset Corporation

Las Vegas, NV, US
501(c)3
EIN
84-3753195
Single Organization Support

Nevada Health and Bioscience Asset Corporation

Las Vegas, NV, US
501(c)3
EIN
84-3753195
Single Organization Support

Balance Sheet

Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)

$177,692,754

Property, Plant, & Equipment (net)
73%
Cash & Equivalents
27%
Receivables (Non-Related)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)

$68,052,771

Other Liabilities
76%
Deferred Revenue
24%
Payables & Accruals
<1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$67,954,421
$48,374,966
-29%
Receivables (Non-Related)
$485,760
$419,922
-14%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$65,558
$60,961
-7%
Investments
-
-
-
Property, Plant, & Equipment (net)
$131,947,269
$128,836,905
-2%
Other Assets
-
-
-
Total Assets
$200,453,008
$177,692,754
-11%
Liabilities
2023
2024
Change
Payables & Accruals
$406,155
$233,480
-43%
Grants Payable
-
-
-
Deferred Revenue
$35,000,000
$16,208,841
-54%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$55,905,892
$51,610,450
-8%
Total Liabilities
$91,312,047
$68,052,771
-25%
Net assets
2023
2024
Change
Restricted Net Assets
$11,125,192
$13,228,251
+19%
Unrestricted Net Assets
$98,015,769
$96,411,732
-2%
Net assets
2023
2024
Change
Net assets
+$109,140,961
+$109,639,983
+0%
Balance Sheet
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)